MWP
ZSAN

Meridian Wealth Partners’s Zosano Pharma Corporation ZSAN Stock Holding History

Meridian Wealth Partners’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22
Closed -$1K – 1441
2021
Q1 		$1K Buy
+22
New +$921 ﹤0.01% 1299

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Meridian Wealth Partners's ZSAN Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Zosano Pharma Corporation (ZSAN) in Q2 2021, closing a stake of 22 shares — an estimated $1K sold.

Meridian Wealth Partners first reported a position in ZSAN in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 34 funds tracked by Wall St. Rank hold ZSAN as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Zosano Pharma Corporation position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 22 Zosano Pharma Corporation shares in Q2 2021, an estimated $1K.
  • Meridian Wealth Partners first reported a position in Zosano Pharma Corporation in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Zosano Pharma Corporation position peaked at $1K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.